Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
A completed real-world study evaluating vedolizumab use in adults with inflammatory bowel diseases (Crohn's disease and ulcerative colitis) …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) [Phase 2]
A Phase 2 continuation study of TAK-279 in adults with ulcerative colitis and Crohn's disease, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio [Phase 3]
A Phase 3 trial comparing AVT16 with Entyvio in ulcerative colitis has been terminated; the update does not provide results.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis [Phase 4]
A Phase 4 clinical trial is investigating de-escalation of ustekinumab therapy in Crohn's disease and ulcerative colitis and is currently re…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. [Phase 3]
A Phase 3 pediatric study is evaluating adverse events, changes in disease activity, and pharmacokinetics of oral upadacitinib in moderately…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis
Clinical trial update reports the completion of a study of Vedolizumab (Kynteles) in adults with moderate-to-severe ulcerative colitis, Croh…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) [Phase 3]
Phase 3 extension study protocol evaluating long-term safety and efficacy of Tulisokibart in participants with Crohn disease or Ulcerative c…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
A prospective observational study evaluating the effectiveness and safety of filgotinib in patients with ulcerative colitis. The study statu…
-
CLINICAL_TRIALS other · 2025-12-24Clinical Trial Update: Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial [Phase 2]
A Phase 2 CINTO trial is evaluating the combination of infliximab and tofacitinib for acute severe ulcerative colitis; the study status is n…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Food Limitations In Crohn's Disease and Ulcerative coliTis [NA]
Clinical trial update indicating a study on food limitations in Crohn's disease and ulcerative colitis is not yet recruiting, with no specif…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 study of ABBV-668 oral capsules in adults with moderate-to-severe Ulcerative Colitis has completed with results posted, detailing ad…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis [Phase 3]
Phase 3 clinical trial evaluating intravenous vedolizumab in Chinese participants with moderately to severely active ulcerative colitis; rec…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Impact of a Physical Activity Program on Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease [NA]
A completed clinical trial assessed whether a structured physical activity program improves bone mineral density in children and adolescents…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Occupational Insertion and Educational Level of Adult Patients With Pediatric Early Inflammatory Bowel Disease (IBD)
A clinical trial update for a study investigating occupational activity and educational level in adults with pediatric-onset inflammatory bo…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING) [NA]
A completed pediatric trial examining whether extracellular DNA can amplify inflammation in inflammatory bowel disease via the cGAS-STING pa…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial [Phase 2]
Phase 2 feasibility randomized trial evaluating modafinil for fatigue in inflammatory bowel disease (Crohn's disease and ulcerative colitis)…
-
EMA withdrawal · 2025-12-18EMA Withdrawn: Absimky (ustekinumab) — Accord Healthcare S.L.U.
EMA has withdrawn Absimky (ustekinumab) from Accord Healthcare S.L.U., affecting its use for Crohn disease and ulcerative colitis.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe
A clinical trial is examining the prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease at CHU de la Guade…
-
CLINICAL_TRIALS withdrawal · 2025-12-17Clinical Trial Update: VE202 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]
A Phase 2 trial of VE202 in Ulcerative Colitis has been terminated.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients [NA]
A clinical trial update for an oral vitamin D3 study assessing its effect on inflammatory biomarkers in patients with ulcerative colitis, cu…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of PF-06480605 in adults with moderate to severe ulcerative colitis has completed. Results …
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis [Phase 4]
A Phase 4 clinical trial compares top-down therapy with mirikizumab versus standard-of-care azathioprine in newly diagnosed moderate-to-seve…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC [Phase 2]
A Phase 2 trial of MORF-057 in adults with moderately to severely active ulcerative colitis has posted results, and the study is currently n…
-
EMA approval · 2025-12-15EMA Authorised: Remicade (infliximab) — Janssen Cilag International NV
The EMA has authorised Remicade (infliximab) for multiple inflammatory diseases under Janssen Cilag International NV as the marketing author…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab)) [Phase 2]
A Phase 2 study evaluating dupilumab versus placebo in adults with moderately to severely active ulcerative colitis with an eosinophilic phe…